PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
April 26, 2024CancersOpen Access

Assessing the Predictive Accuracy of EORTC, CUETO and EAU Risk Stratification Models for High-Grade Recurrence and Progression after Bacillus Calmette–Guérin Therapy in Non-Muscle-Invasive Bladder Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

AŚAleksander ŚlusarczykKGKarolina GarbasPPPatryk Pustuła

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ślusarczyk et al. (2024) studied this question.

synapsesocial.com/papers/68e6d598b6db6435876530cdhttps://doi.org/10.3390/cancers16091684
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Outcomes of BCG Therapy in Patients with High and Very High-Risk Non-Muscle-Invasive Bladder Cancer: Reassessing EAU Risk Stratification2025
  2. 2Comparative efficacy of Bacillus Calmette–Guérin instillation and radical cystectomy treatments for high-risk non-muscle-invasive urothelial cancer classified as high-grade T1 in initial and repeat transurethral resection of bladder tumor2024 · 1 citations
  3. 3High Oncological Efficacy of BCG Maintenance Therapy for Primary High-Grade T1 Urothelial Carcinoma of the Bladder2026
  4. 4Prediction of recurrence using hematologic and urinary markers in intravesical Bacillus calmette Guerin treated bladder cancer2025
  5. 5Refining <scp>BCG</scp> ‐failure classifications in non‐muscle‐invasive bladder cancer2026 · 2 citations